Miguel Zugman
and Benjamin L Maughan
Aug 9, 2025, 16:39
Benjamin L Maughan: Miguel Zugman Presented Interesting Results KCRS 2025
Benjamin L Maughan, Genitourinary Oncologist at Huntsman Cancer Institute, shared on X:
“Miguel Zugman presented interesting results KCRS 2025 – cabo seems equivalent to TKI/IO. Since there seems no immunologic synergy in the long-term f/u studies in RCC and other cancers, our patients deserve randomized data. with SAMETA and STELLAR closed please consider PAPMET2!”
Miguel Zugman, Postdoctoral fellow at City of Hope, shared Benjamin L Maughan’s post on X:
“Grateful for the highlight. Couldn’t agree more: papillary RCC needs randomized data. Let’s make PAPMET2 happen!”
More posts featuring Miguel Zugman and Benjamin Maughan.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 25, 2025, 15:19
Aug 25, 2025, 15:11
Aug 25, 2025, 15:06
Aug 25, 2025, 14:53
Aug 25, 2025, 14:44
Aug 25, 2025, 14:42
Aug 25, 2025, 14:32